BSE filing, NSE: PASUFIN. Summary written from the filing by ALFA Finder's alert engine.
Pasupati Fincap Ltd: key numbers
- Share price
- ₹36.97
- Market cap
- ₹17.38 Cr
- Revenue (annual)
- ₹0.09 Cr
- Net profit (annual)
- ₹-0.30 Cr
- P/E (TTM)
- 150.1×Sector 19.7×
- Promoter holding
- 11.55%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pasupati Fincap Ltd
All →Pasupati Fincap Open Offer
Fintellectual, Manager to the Open Offer, filed the Post-Offer Advertisement under SAST Reg 18(12). It covers Uday Narang's offer for up to 12.22 lakh Pasupati Fincap shares.
Pasupati Fincap Annual General Meeting
Pasupati Fincap Limited filed the summary of proceedings for its 31st Annual General Meeting held on September 28, 2026, via video conferencing.
Pasupati Fincap Open Offer: ₹1.47 Cr
Uday Narang (Acquirer) has issued a Letter of Offer to acquire 12.22 lakh shares of Pasupati Fincap Ltd at ₹12 per share, amounting to ₹1.47 Crore.
- Value
- ₹1.47 Cr
- From
- Uday Narang (Acquirer)
Pasupati Fincap Management Change
Pasupati Fincap Limited has appointed Mr. Sagar Singh Rawat as the Company Secretary and Compliance Officer, effective September 10, 2026.
Pasupati Fincap Annual General Meeting
Pasupati Fincap Limited issued a notice for its 31st Annual General Meeting to be held on September 28, 2026, through video conferencing.
Pasupati Fincap Annual Report
Pasupati Fincap Ltd has submitted its 31st Annual Report for the Financial Year 2025-26, along with the notice of the upcoming Annual General Meeting.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.